To further investigate whether MSCs exist in the metastatic sites, CMFDA-labeled MSCs from lal+/+ and lal−/− mice were intravenously co-injected with B16 melanoma cells into the allogeneic FVB/N lal+/+ mice. This evidence concerns the gene LIPA and melanoma.